Biosynthetic Breakthroughs: Paving the Way for Future Drug Development

Join Christina Smolke, CEO and Co-founder, Antheia, Inc. and Adjunct Professor of Bioengineering of Stanford University as she discusses how biosynthetic technology can expand the number and diversity of drugs that can be made with fermentation technology. Following this discussion, Yi Tang, Chancellor Professor of the Department of Chemical and Biomolecular Engineering at UCLA will present recent advances in the biosynthesis of natural products in microorganisms with a focus on new approaches in genome mining of natural products like fungi to create novel structures, activities, and completely new compounds.

This ACS Webinar is moderated by Catherine Goodman, Senior Associate Publisher at the American Chemical Society and co-produced with ACS Publications and the ACS Division of Medicinal Chemistry.

What You Will Learn

• How synthetic biology can enable a transformation in pharma manufacturing to more efficient, cost-effective, transparent, and agile models
• How synthetic biology can be combined with natural product chemistry to drive discoveries
• Methods to prioritize biosynthetic gene clusters for genome mining

Meet The Experts

Christina Smolke, CEO and Co-founder, Antheia, Inc. and Adjunct Professor, Bioengineering, Stanford University

Yi Tang, Principal, Parsons Family Professor, Department of Chemical and Biomolecular Engineering, Department of Chemistry and Biochemistry, UCLA

Catherine Goodman, Senior Associate Publisher, American Chemical Society